Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Waltham, Massachusetts
- Most recent report
- 10-Q, filed Nov 4, 2026
- Incorporated
- Delaware
- Filings on record
- 353 filings
- On EDGAR
- CIK 1800315
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 25
News 8 of 41
- 8-K Significant contract Jul 20, 2026
- 8-K Shareholder vote results Jun 17, 2026
- 8-K Leadership change May 4, 2026
- 8-K Current report on a material event Apr 20, 2026
- 8-K Leadership change Mar 23, 2026
- 8-K Quarterly results Mar 10, 2026
- 8-K Significant contract Feb 11, 2026
- 8-K Leadership change Feb 10, 2026
Prospectuses and Registrations 8 of 28
- S-8 POS Post-effective amendment to an employee plan registration Aug 10, 2026
- S-8 POS Post-effective amendment to an employee plan registration Aug 10, 2026
- S-8 POS Post-effective amendment to an employee plan registration Aug 10, 2026
- S-8 POS Post-effective amendment to an employee plan registration Aug 10, 2026
- S-8 POS Post-effective amendment to an employee plan registration Aug 10, 2026
- S-8 POS Post-effective amendment to an employee plan registration Aug 10, 2026
- S-8 POS Post-effective amendment to an employee plan registration Aug 10, 2026
- S-8 POS Post-effective amendment to an employee plan registration Aug 10, 2026
Proxies 8 of 15
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2026
- DEFA14A Extra proxy material Apr 29, 2026
- DEF 14A Proxy statement for a shareholder vote Dec 31, 2025
- PRE 14A Preliminary proxy statement Dec 16, 2025
- DEFA14A Extra proxy material Apr 30, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2025
- PRE 14A Preliminary proxy statement Apr 17, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2024
Ownership 8 of 218
- 4 Insider reported a trade Sep 28, 2026
- 4 Insider reported a trade Aug 13, 2026
- 3 Insider reported their initial holding Aug 13, 2026
- 144 Notice of a proposed sale of restricted stock Aug 6, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 28, 2026
- 4 Insider reported a trade Jul 7, 2026
- 144 Notice of a proposed sale of restricted stock Jun 22, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 15, 2026
Other 8 of 26
- EFFECT Notice that a registration became effective Aug 12, 2026
- POSASR Aug 10, 2026
- 8-A12B/A Registration of a security for exchange listing, amended Aug 10, 2026
- ARS Annual report sent to shareholders May 1, 2026
- EFFECT Notice that a registration became effective Dec 23, 2025
- CORRESP Reply to SEC staff Dec 22, 2025
- D Nov 21, 2025
- ARS Annual report sent to shareholders Apr 30, 2025
Everything here comes from Damora Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.